Pharmaceutical firms and the construction of drug markets: From branding to scientific marketing:
Saved in:
| Format: | Book |
|---|---|
| Language: | English |
| Published: |
[London]
Routledge
2013
|
| Series: | History and technology
29,2 : Special issue |
| Subjects: | |
| Item Description: | Einzelaufnahme eines Zs.-Heftes |
| Physical Description: | S. 105-226 |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV042240631 | ||
| 003 | DE-604 | ||
| 005 | 20141218 | ||
| 007 | t | ||
| 008 | 141216s2013 |||| 00||| eng d | ||
| 035 | |a (OCoLC)898425493 | ||
| 035 | |a (DE-599)GBV788345885 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-706 | ||
| 245 | 1 | 0 | |a Pharmaceutical firms and the construction of drug markets: From branding to scientific marketing |c hrsg.: Martin Collins |
| 246 | 1 | 0 | |a Pharmaceutical firms and the construction of drug markets: From branding to scientific marketing |
| 264 | 1 | |a [London] |b Routledge |c 2013 | |
| 300 | |a S. 105-226 | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a History and technology |v 29,2 : Special issue | |
| 500 | |a Einzelaufnahme eines Zs.-Heftes | ||
| 650 | 0 | 7 | |a Marketing |0 (DE-588)4037589-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |D s |
| 689 | 0 | 1 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 2 | |a Marketing |0 (DE-588)4037589-4 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Collins, Martin |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-027678767 | ||
Record in the Search Index
| _version_ | 1804152780650184704 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV042240631 |
| ctrlnum | (OCoLC)898425493 (DE-599)GBV788345885 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01383nam a2200373 cb4500</leader><controlfield tag="001">BV042240631</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20141218 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">141216s2013 |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)898425493</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBV788345885</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-706</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmaceutical firms and the construction of drug markets: From branding to scientific marketing</subfield><subfield code="c">hrsg.: Martin Collins</subfield></datafield><datafield tag="246" ind1="1" ind2="0"><subfield code="a">Pharmaceutical firms and the construction of drug markets: From branding to scientific marketing</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[London]</subfield><subfield code="b">Routledge</subfield><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">S. 105-226</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">History and technology</subfield><subfield code="v">29,2 : Special issue</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zs.-Heftes</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Marketing</subfield><subfield code="0">(DE-588)4037589-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Marketing</subfield><subfield code="0">(DE-588)4037589-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Collins, Martin</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027678767</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV042240631 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T01:16:09Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027678767 |
| oclc_num | 898425493 |
| open_access_boolean | |
| owner | DE-706 |
| owner_facet | DE-706 |
| physical | S. 105-226 |
| publishDate | 2013 |
| publishDateSearch | 2013 |
| publishDateSort | 2013 |
| publisher | Routledge |
| record_format | marc |
| series2 | History and technology |
| spelling | Pharmaceutical firms and the construction of drug markets: From branding to scientific marketing hrsg.: Martin Collins Pharmaceutical firms and the construction of drug markets: From branding to scientific marketing [London] Routledge 2013 S. 105-226 txt rdacontent n rdamedia nc rdacarrier History and technology 29,2 : Special issue Einzelaufnahme eines Zs.-Heftes Marketing (DE-588)4037589-4 gnd rswk-swf Arzneimittelmarkt (DE-588)4003131-7 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Arzneimittelmarkt (DE-588)4003131-7 s Pharmazeutische Industrie (DE-588)4045696-1 s Marketing (DE-588)4037589-4 s DE-604 Collins, Martin Sonstige oth |
| spellingShingle | Pharmaceutical firms and the construction of drug markets: From branding to scientific marketing Marketing (DE-588)4037589-4 gnd Arzneimittelmarkt (DE-588)4003131-7 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd |
| subject_GND | (DE-588)4037589-4 (DE-588)4003131-7 (DE-588)4045696-1 (DE-588)4143413-4 |
| title | Pharmaceutical firms and the construction of drug markets: From branding to scientific marketing |
| title_alt | Pharmaceutical firms and the construction of drug markets: From branding to scientific marketing |
| title_auth | Pharmaceutical firms and the construction of drug markets: From branding to scientific marketing |
| title_exact_search | Pharmaceutical firms and the construction of drug markets: From branding to scientific marketing |
| title_full | Pharmaceutical firms and the construction of drug markets: From branding to scientific marketing hrsg.: Martin Collins |
| title_fullStr | Pharmaceutical firms and the construction of drug markets: From branding to scientific marketing hrsg.: Martin Collins |
| title_full_unstemmed | Pharmaceutical firms and the construction of drug markets: From branding to scientific marketing hrsg.: Martin Collins |
| title_short | Pharmaceutical firms and the construction of drug markets: From branding to scientific marketing |
| title_sort | pharmaceutical firms and the construction of drug markets from branding to scientific marketing |
| topic | Marketing (DE-588)4037589-4 gnd Arzneimittelmarkt (DE-588)4003131-7 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd |
| topic_facet | Marketing Arzneimittelmarkt Pharmazeutische Industrie Aufsatzsammlung |
| work_keys_str_mv | AT collinsmartin pharmaceuticalfirmsandtheconstructionofdrugmarketsfrombrandingtoscientificmarketing |